Geode Capital Management
MIRA icon

Geode Capital Management’s MIRA Pharmaceuticals MIRA Stock Holding History

Geode Capital Management’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$288K Buy
303,882
+12,992
+4% +$13.1K ﹤0.01% 3798
2026
Q1 		$311K Buy
290,890
+18,012
+7% +$22.6K ﹤0.01% 3762
2025
Q4 		$412K Buy
272,878
+136,438
+100% +$200K ﹤0.01% 3667
2025
Q3 		$186K Buy
136,440
+1,145
+0.8% +$1.66K ﹤0.01% 3945
2025
Q2 		$164K Sell
135,295
-123
-0.1% -$142 ﹤0.01% 3940
2025
Q1 		$133K Buy
135,418
+13,332
+11% +$15.2K ﹤0.01% 3951
2024
Q4 		$139K Buy
122,086
+6,172
+5% +$8.06K ﹤0.01% 4005
2024
Q3 		$151K Buy
+115,914
New +$185K ﹤0.01% 3989

Other funds holding MIRA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Geode Capital Management's MIRA Position: Q2 2026 in Review

Geode Capital Management increased its MIRA Pharmaceuticals (MIRA) stake by 4.5% in Q2 2026, buying an estimated $13.1K and bringing the position to 303,882 shares worth $288K. The position accounts for ﹤0.01% of the portfolio, ranked #3798.

Geode Capital Management first reported a position in MIRA in Q3 2024 and has held it in 8 quarters since. The position peaked at $412K in Q4 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q2 2026.

  • Geode Capital Management held 303,882 shares of MIRA Pharmaceuticals worth $288K as of Q2 2026.
  • Geode Capital Management bought 12,992 MIRA Pharmaceuticals shares in Q2 2026, an estimated $13.1K.
  • MIRA Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3798 holding.
  • Geode Capital Management first reported a position in MIRA Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • Geode Capital Management's MIRA Pharmaceuticals position peaked at $412K in Q4 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.